NEW YORK (GenomeWeb News) — Clinical Data expects to gross $66 million in a previously disclosed plan to offer 3 million shares of its common stock. The offering would price the shares at $22 apiece, the company said today.
  
Clinical Data plans to pump some of the proceeds into clinical trials, preclinical R&D, and expenses, acquisitions, and working capital.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.